These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25638199)

  • 21. Hemophagocytic lymphohistiocytosis at initiation of kawasaki disease and their differential diagnosis.
    Chen Y; Shang S; Zhang C; Liu T; Yang Z; Tang Y
    Pediatr Hematol Oncol; 2010 Apr; 27(3):244-9. PubMed ID: 20367269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The dynamic roles of angiopoietin-1 and -2.
    Tasaki Y; Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Wada T; Yachie A
    Cytokine; 2016 Apr; 80():1-6. PubMed ID: 26908294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kawasaki disease preceding haemophagocytic lymphohistiocytosis: challenges for developing world practitioners.
    Hendricks M; Pillay S; Davidson A; De Decker R; Lawrenson J
    Pediatr Blood Cancer; 2010 Jul; 54(7):1023-5. PubMed ID: 20135702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kawasaki disease shock syndrome and macrophage activation syndrome.
    Yang HF; Fan HC
    Paediatr Int Child Health; 2018 Nov; 38(4):310. PubMed ID: 30257616
    [No Abstract]   [Full Text] [Related]  

  • 25. Should refractory Kawasaki disease be considered occult macrophage activation syndrome?
    Choi UY; Han SB; Lee SY; Jeong DC
    Semin Arthritis Rheum; 2017 Feb; 46(4):e17. PubMed ID: 27639924
    [No Abstract]   [Full Text] [Related]  

  • 26. Macrophage activation syndrome in Kawasaki disease: more common than we thought?
    Wang W; Gong F; Zhu W; Fu S; Zhang Q
    Semin Arthritis Rheum; 2015 Feb; 44(4):405-10. PubMed ID: 25200945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The link between Kawasaki disease shock syndrome and macrophage activation syndrome in terms of organ dysfunction observed in children with systemic inflammatory response syndrome.
    Han SB; Lee SY
    Paediatr Int Child Health; 2018 Nov; 38(4):308-309. PubMed ID: 30253701
    [No Abstract]   [Full Text] [Related]  

  • 28. High-Volume Hemofiltration in Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Prospective Study in the PICU.
    Cui Y; Zhang YC; Kang YL; Ren YQ; Miao HJ; Wang F
    Pediatr Crit Care Med; 2016 Oct; 17(10):e437-e443. PubMed ID: 27487914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage Activation Syndrome.
    Ravelli A; Davì S; Minoia F; Martini A; Cron RQ
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):927-41. PubMed ID: 26461152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?
    Han SB; Lee SY; Jeong DC; Kang JH
    Ann Rheum Dis; 2016 Jul; 75(7):e44. PubMed ID: 26965982
    [No Abstract]   [Full Text] [Related]  

  • 31. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.
    Avcin T; Tse SM; Schneider R; Ngan B; Silverman ED
    J Pediatr; 2006 May; 148(5):683-6. PubMed ID: 16737887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.
    Moling O; Piccin A; Tauber M; Marinello P; Canova M; Casini M; Negri G; Raffeiner B; Binazzi R; Gandini L; Vecchiato C; Rimenti G; Billio A
    J Med Case Rep; 2016 Sep; 10(1):254. PubMed ID: 27634631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis.
    Rosado FG; Kim AS
    Am J Clin Pathol; 2013 Jun; 139(6):713-27. PubMed ID: 23690113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemophagocytic syndrome after Kawasaki disease.
    Palazzi DL; McClain KL; Kaplan SL
    Pediatr Infect Dis J; 2003 Jul; 22(7):663-6. PubMed ID: 12886898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic-onset juvenile idiopathic arthritis and incomplete Kawasaki disease may belong to a single clinical syndrome within a spectrum of severity.
    Han SB; Lee SY
    Clin Exp Rheumatol; 2019; 37 Suppl 122(6):3. PubMed ID: 28980895
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mucocutaneous lymph node syndrome (Kawasaki syndrome) from the cardiological viewpoint].
    Wassmann M; Sieverding L; Apitz J
    Dtsch Krankenpflegez; 1991 Feb; 44(2):123-5. PubMed ID: 1900770
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease.
    Dong S; Bout-Tabaku S; Texter K; Jaggi P
    J Pediatr; 2015 May; 166(5):1283-8. PubMed ID: 25771391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kawasaki disease (mucocutaneous lymph node syndrome). Report of 7 cases and brief review].
    Sakane PT; de Mendonça JS; Mazzucato G; Pannuti CS; Amato Neto V
    Rev Paul Med; 1983; 101(2):62-7. PubMed ID: 6622895
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute myocardial infarction in a 5-year old child--mucocutaneous lymph node syndrome (Kawasaki disease). A case report].
    Vieira EJ; Tuppy GH; Kawamura T
    Arq Bras Cardiol; 1986 Jan; 46(1):49-52. PubMed ID: 3813924
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kawasaki disease (mucocutaneous lymph node syndrome in children)].
    Zernov NG; Kostikov MV; Fedorov AM
    Pediatriia; 1983 Apr; (4):71-3. PubMed ID: 6348691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.